- Both companies operate in the same market and are of similar size and produce comparable growth rates, yet CryoPort sells at 2.5x the valuation of BioLife.
- Operationally BioLife is much superior in terms of profits, cash flow, margins compared with CryoPort’s history of losses, cash burn, lower margins, debt and dilution.
- CryoPort has a more established distribution business but don’t count the distribution business of BioLive out just yet, as they had a notable customer win recently.
BioLife’s Huge Valuation Gap With CryoPort Is Difficult To Explain
July 13th, 2019 · No Comments